Headquarters
170 PARK AVE, FLORHAM PARK, NJ 07932-1049, US
FLORHAM PARK, NJ, US
From the company
Celularity Inc. (NASDAQ: CELU) is a clinical and commercial stage biotechnology company developing and commercializing off-the-shelf placental-derived allogeneic cell therapies and advanced biomaterial products targeting age-related diseases and serious unmet medical needs. Its platform includes mesenchymal-like adherent stromal cells (MLASCs), Natural Killer (NK) cells, and engineered T cells including CAR-T cells. It operates a purpose-built 150,000 sq ft facility in Florham Park, NJ.
170 PARK AVE, FLORHAM PARK, NJ 07932-1049, US
Quantities, certifications, and timing.